PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Internal Medicine, Infanta Leonor University Hospital, Madrid, Spain. jestrogar@hotmail.com.\', \'Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, Paris, France.\', \'Imagine Institute, University of Paris, Paris, France.\', \'St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, Rockefeller University, New York, NY, USA.\', \'Neurometabolic Diseases Laboratory, Bellvitge Biomedical Research Institute (IDIBELL), L\'Hospitalet de Llobregat, Barcelona, Spain.\', \'Department of Internal Medicine, Infanta Leonor University Hospital, Madrid, Spain.\', \'Intensive Care Unit, Infanta Leonor University Hospital, Madrid, Spain.\', \'Howard Hughes Medical Institute, New York, NY, USA.\', \'Centre for Biomedical Research in Network on Rare Diseases (CIBERER), Instituto de Salud Carlos III, 28029, Madrid, Spain.\', \'Catalan Institution of Research and Advanced Studies (ICREA), Barcelona, Catalonia, Spain.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/s10875-021-01036-0
?:doi
?:hasPublicationType
?:journal
  • Journal of clinical immunology
is ?:pmid of
?:pmid
?:pmid
  • 33851338
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.611
?:rankingScore_hIndex
  • 84
is ?:relation_isRelatedTo_publication of
?:title
  • Neutralizing Autoantibodies to Type I IFNs in >10% of Patients with Severe COVID-19 Pneumonia Hospitalized in Madrid, Spain.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all